Point prevalence surveys of antimicrobial use: a systematic review and the implications

References

• Alharbi SA, Wainwright M, Alahmadi TA, et al. What if Fleming had not discovered penicillin? Saudi J Biol Sci. 2014;21(4):289–293.
   PubMed Web of Science ®Google Scholar
• Laxminarayan R, Matsoso P, Pant S, et al. Access to effective antimicrobials: a worldwide challenge. Lancet. 2016;387(10014):168–175.
   PubMed Web of Science ®Google Scholar
• Md Rezal RS, Hassali MA, Alrasheedy AA, et al. Physicians’ knowledge, perceptions and behaviour towards antibiotic prescribing: a systematic review of the literature. Expert Rev Anti Infect Ther. 2015;13(5):665–680.
   PubMed Web of Science ®Google Scholar
• Godman B, Fadare J, Kibuule D, et al. Drug resistance in bacteria, fungi, malaria, and cancer. In: Arora, Sajid, & Kalia, editors. Initiatives across countries to reduce antibiotic utilisation and resistance patterns: impact and implications. Springer, 2017.p. 539–576.
   Google Scholar
• Van Nguyen K, Do NTT, Chandna A, et al. Antibiotic use and resistance in emerging economies: a situation analysis for Viet Nam. BMC Public Health. 2013;13(1):1158.
   PubMed Web of Science ®Google Scholar
• Bell BG, Schellevis F, Stobberingh E, et al. A systematic review and meta-analysis of the effects of antibiotic consumption on antibiotic resistance. BMC Infect Dis. 2014;14(1):13.
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA. Travellers take heed: outbreak of extensively drug resistant (XDR) typhoid fever in Pakistan and a warning from the US CDC. Travel Med Infect Dis. 2018;27:124.
   Web of Science ®Google Scholar
• Laxminarayan R, Duse A, Wattal C, et al. Antibiotic resistance—the need for global solutions. Lancet Infect Dis. 2013;13(12):1057–1098.
   PubMed Web of Science ®Google Scholar
• Cassini A, Hogberg LD, Plachouras D, et al. Attributable deaths and disability-adjusted life-years caused by infections with antibiotic-resistant bacteria in the EU and the European Economic Area in 2015: a population-level modelling analysis. Lancet Infect Dis. 2019;19(1):56–66.
   PubMed Web of Science ®Google Scholar
• Founou RC, Founou LL, Essack SY. Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis. PloS One. 2017;12(12):e0189621.
   PubMed Web of Science ®Google Scholar
• OECD Health Policy. Studies, stemming the superbug tide. 2018. [cited 2018 May 12]. Available from: https://www.oecd-ilibrary.org/sites/9789264307599-en/index.html?itemId=/content/publication/9789264307599-en&mimeType=text/html
   Google Scholar
• Hofer U. The cost of antimicrobial resistance. Nat Rev Microbiol. 2019;17(1):3.
   PubMedGoogle Scholar
• O’Neill J. Antimicrobial resistance: tackling a crisis for the health and wealth of nations. The Review on Antimicrobial Resistance. 2014. [cited 2018 Jun 11]. Available from: https://amr review.org/sites/default/files/AMR%20Review%20Paper%20 %20Tackling%20a%20crisis%20for%20the%20health%20and%20wealth%20of%20nations_1.pdf
   Google Scholar
• World Health Organization. Global action plan on antimicrobial resistance. 2015. [cited 2018 Jun 10]. Available from: http://www.who.int/antimicrobial-resistance/publications/global-action-plan/en/
   Google Scholar
• World Health Organization WH. World health assembly addresses antimicrobial resistance, immunization gaps and malnutrition. 2015. [cited 2018 Jun 10]. Available from: http://www.who.int/mediacentre/news/releases/2015/wha-25-may-2015/en/
   Google Scholar
• Saleem Z, Hassali MA, Hashmi FK. Pakistan’s national action plan for antimicrobial resistance: translating ideas into reality. Lancet Infect Dis. 2018;18(10):1066–1067.
   PubMed Web of Science ®Google Scholar
• Jinks T, Lee N, Sharland M, et al. A time for action: antimicrobial resistance needs global response. Bull World Health Organ. 2016;94(8):558–558A.
   PubMed Web of Science ®Google Scholar
• Boucher HW, Bakken JS, Murray BE. The United Nations and the urgent need for coordinated global action in the fight against antimicrobial resistance coordinated global action to fight against antimicrobial resistance. Ann Intern Med. 2016;165(11):812–813.
   PubMed Web of Science ®Google Scholar
• Versporten A, Bielicki J, Drapier N, et al. The worldwide Antibiotic Resistance and Prescribing in European Children (ARPEC) point prevalence survey: developing hospital-quality indicators of antibiotic prescribing for children. J Antimicrob Chemother. 2016;71(4):1106–1117.
   PubMed Web of Science ®Google Scholar
• Woodward M. Epidemiology: study design and data analysis. Boca Raton, FL: CRC press; 2013.
   Google Scholar
• Aldeyab MA, Kearney MP, McElnay JC, et al. A point prevalence survey of antibiotic prescriptions: benchmarking and patterns of use. Br J Clin Pharmacol. 2011;71(2):293–296.
   PubMed Web of Science ®Google Scholar
• Xie D-S, Xiang L-L, Li R, et al. A multicenter point-prevalence survey of antibiotic use in 13 Chinese hospitals. J Infect Public Health. 2015;8(1):55–61.
   PubMed Web of Science ®Google Scholar
• Zarb P, Coignard B, Griskeviciene J, et al. The European Centre for Disease Prevention and Control (ECDC) pilot point prevalence survey of healthcare-associated infections and antimicrobial use. Euro Surveill. 2012;17(46):20316.
   PubMedGoogle Scholar
• Massele A, Tiroyakgosi C, Matome M, et al. Research activities to improve the utilization of antibiotics in Africa. Expert Rev Pharmacoecon Outcomes Res. 2017;17(1):1–4.
   PubMed Web of Science ®Google Scholar
• Versporten A, Zarb P, Caniaux I, et al. Antimicrobial consumption and resistance in adult hospital inpatients in 53 countries: results of an internet-based global point prevalence survey. Lancet Glob Health. 6(6): e619–29. 2018.
   PubMed Web of Science ®Google Scholar
• Van Boeckel TP, Gandra S, Ashok A, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014;14(8):42–750.
   Web of Science ®Google Scholar
• Marquet K, Liesenborgs A, Bergs J, et al. Incidence and outcome of inappropriate in-hospital empiric antibiotics for severe infection: a systematic review and meta-analysis. Crit Care. 2015;19(1):63.
   PubMedGoogle Scholar
• Morgan DJ, Okeke IN, Laxminarayan R, et al. Non-prescription antimicrobial use worldwide: a systematic review. Lancet Infect Dis. 2011;11(9):692–701.
   PubMed Web of Science ®Google Scholar
• Keller SC, Tamma PD, Cosgrove SE, et al. Ambulatory antibiotic stewardship through a human factors engineering approach: a systematic review. J Am Board Family Med. 2018;31(3):417–430.
   PubMed Web of Science ®Google Scholar
• Costelloe C, Metcalfe C, Lovering A, et al. Effect of antibiotic prescribing in primary care on antimicrobial resistance in individual patients: systematic review and meta-analysis. BMJ. 2010;340:c2096.
   PubMed Web of Science ®Google Scholar
• Plachouras D, Karki T, Hansen S, et al. Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017. Euro Surveill. 2018;23(46):1-14.
   Google Scholar
• Zarb P, Goossens H. European Surveillance of Antimicrobial Consumption (ESAC): value of a point-prevalence survey of antimicrobial use across Europe. Drugs. 2011;71(6):745–755.
   PubMed Web of Science ®Google Scholar
• Ansari F, Erntell M, Goossens H, et al., Group EIHCS. The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006. Clin Infect Dis. 2009;49(10):1496–1504.
   PubMed Web of Science ®Google Scholar
• WHO. WHO collaborating centre for drug statistics methodology. ATC/DDD Index. [cited 2018 May 21]. Available from: https://www.whocc.no/
   Google Scholar
• Singh S, Jose T, Versporten A, et al. A point prevalence surveillance study from pediatric and neonatal specialty hospitals in India. J Pediatr Infect Dis. 2014;9(3):151–155.
   Google Scholar
• Momanyi L, Opanga S, Nyamu D, et al. Antibiotic prescribing patterns at a leading referral hospital in Kenya: a point prevalence survey. J Res Pharm Pract. 2019;8(3):149.
   PubMed Web of Science ®Google Scholar
• Soltani J, Pouladfar G, Versporten A, et al. Point prevalence survey of antimicrobial prescription and infection in pediatric and neonatal wards of two Iranian teaching hospitals. Erciyes Med J/Erciyes Tip Dergisi. 2019;41(1):25–32.
   Web of Science ®Google Scholar
• Gharbi M, Doerholt K, Vergnano S, et al. Using a simple point-prevalence survey to define appropriate antibiotic prescribing in hospitalised children across the UK. BMJ Open. 2016;6(11):e012675.
   PubMed Web of Science ®Google Scholar
• Ang L, Laskar R, Gray J. A point prevalence study of infection and antimicrobial use at a UK children’s hospital. J Hosp Infect. 2008;68(4):372–374.
   PubMed Web of Science ®Google Scholar
• De Luca M. Antibiotic prescriptions and prophylaxis in Italian children. Is it time to change? Data from the ARPEC project. Eur J Clin Microbiol Infect Dis. 2016;11(5):e0154662.
   Google Scholar
• Morioka H, Nagao M, Yoshihara S, et al. The first multi-centre point-prevalence survey in four Japanese university hospitals. J Hosp Infect. 2018;99(3):325–331.
   PubMed Web of Science ®Google Scholar
• Morioka H, Hirabayashi A, Iguchi M, et al. The first point prevalence survey of health care–associated infection and antimicrobial use in a Japanese university hospital: a pilot study. Am J Infect Control. 2016;44(7):e119–23.
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Hashmi FK, et al. A repeated point prevalence survey of antimicrobial use in specialized cancer care hospital of Pakistan: findings and implications. Hosp Pract. 2019;47(3):149–154.
   PubMedGoogle Scholar
• Sheng T, Wijayaratne GB, Dabrera TM, et al. Point-prevalence study of antimicrobial use in public hospitals in southern Sri Lanka identifies opportunities for improving prescribing practices. Infect Control Hosp Epidemiol. 2019;40(2):224–227.
   PubMed Web of Science ®Google Scholar
• Singh SK, Sengupta S, Antony R, et al. Variations in antibiotic use across india–multicentre study through global point prevalence survey. J Hosp Infect. 2019;103(3):280–283.
   PubMed Web of Science ®Google Scholar
• Nair MGV, Sharma SCD, Sahni BAK, et al. Antimicrobial use and antimicrobial resistance in nosocomial pathogens at a tertiary care hospital in Pune. Med J Armed Forces India. 2015;71(2):112–119.
   PubMedGoogle Scholar
• Hammuda A, Hayder S, Elazzazy S, et al. Point prevalence survey of antimicrobial utilization in oncology patients. J Infect Developing Countries. 2013;7(12):990–993.
   Google Scholar
• Al Matar M, Enani M, Binsaleh G, et al. Point prevalence survey of antibiotic use in 26 Saudi hospitals in 2016. J Infect Public Health. 2019;12(1):77–82.
   PubMed Web of Science ®Google Scholar
• Dlamini NN, Meyer JC, Kruger D, et al. Feasibility of using point prevalence surveys to assess antimicrobial utilisation in public hospitals in South Africa: a pilot study and implications. Hosp Pract. 2019;47(2):88–95.
   PubMedGoogle Scholar
• Cotta M, Robertson M, Upjohn L, et al. Using periodic point‐prevalence surveys to assess appropriateness of antimicrobial prescribing in Australian private hospitals. Intern Med J. 2014;44(3):240–246.
   PubMed Web of Science ®Google Scholar
• Ingram P, Seet J, Budgeon C, et al. Point‐prevalence study of inappropriate antibiotic use at a tertiary Australian hospital. Intern Med J. 2012;42(6):719–721.
   PubMed Web of Science ®Google Scholar
• Ho L, Melvani S. Serial point‐prevalence studies to investigate hospital antimicrobial prescribing. J Pharm Pract Res. 2007;37(3):190–193.
   Google Scholar
• Lee C, Walker SA, Daneman N, et al. Point prevalence survey of antimicrobial utilization in a Canadian tertiary-care teaching hospital. J Epidemiol Glob Health. 2015;5(2):143–150.
   PubMed Web of Science ®Google Scholar
• Black E, Neville H, Losier M, et al. Antimicrobial use at Acute Care Hospitals in Nova Scotia: a point prevalence survey. Can J Hosp Pharm. 2018;71(4):234–242.
   PubMed Web of Science ®Google Scholar
• Seaton R, Nathwani D, Burton P, et al. Point prevalence survey of antibiotic use in Scottish hospitals utilising the Glasgow Antimicrobial Audit Tool (GAAT). Int J Antimicrob Agents. 2007;29(6):693–699.
   PubMed Web of Science ®Google Scholar
• Al-Taani GM, Scott M, Farren D, et al. Longitudinal point prevalence survey of antibacterial use in Northern Ireland using the European Surveillance of Antimicrobial Consumption (ESAC) PPS and Global-PPS tool. Epidemiol Infect. 2018;146(8):1–6.
   PubMed Web of Science ®Google Scholar
• Aldeyab M, Kearney M, McElnay J, et al. A point prevalence survey of antibiotic use in four acute-care teaching hospitals utilizing the European Surveillance of Antimicrobial Consumption (ESAC) audit tool. Epidemiol Infect. 2012;140(9):1714–1720.
   PubMed Web of Science ®Google Scholar
• Hansen S, Sohr D, Piening B, et al. Antibiotic usage in German hospitals: results of the second national prevalence study. J Antimicrob Chemother. 2013;68(12):2934–2939.
   PubMed Web of Science ®Google Scholar
• Akhloufi H, Streefkerk RH, Melles DC, et al. Point prevalence of appropriate antimicrobial therapy in a Dutch university hospital. Eur J Clin Microbiol Infect Dis. 2015;34(8):1631–1637.
   PubMed Web of Science ®Google Scholar
• Willemsen I, Van Der Kooij T, Van Benthem B, et al. Appropriateness of antimicrobial therapy: a multicentre prevalence survey in the Netherlands, 2008–2009. Eurosurveillance. 2010;15(46):19715.
   Web of Science ®Google Scholar
• Krasniqi S, Versporten A, Jakupi A, et al. Antibiotic utilisation in adult and children patients in Kosovo hospitals. Eur J Hosp Pharm. 2017;26(3):146–151.
   PubMedGoogle Scholar
• Stefkovicova M, Litvova S, Melus V, et al. Point prevalence study of antimicrobial usage in acute care hospitals in the Slovak Republic. J Hosp Infect. 2016;93(4):403–409.
   PubMed Web of Science ®Google Scholar
• Vlahović‐Palc̆evski V, Dumpis U, Mitt P, et al. Benchmarking antimicrobial drug use at university hospitals in five European countries. Clin Microbiol Infect. 2007;13(3):277–283.
   PubMed Web of Science ®Google Scholar
• Gandra S, Singh SK, Jinka DR, et al. Point Prevalence surveys of antimicrobial use among Hospitalized Children in Six Hospitals in India in 2016. Antibiotics. 2017;6(3):19.
   Google Scholar
• Ceyhan M, Yildirim I, Ecevit C, et al. Inappropriate antimicrobial use in Turkish pediatric hospitals: a multicenter point prevalence survey. Inter J Infect Dis. 2010;14(1):e55–e61.
   PubMed Web of Science ®Google Scholar
• Labi A-K, Obeng-Nkrumah N, Sunkwa-Mills G, et al. Antibiotic prescribing in paediatric inpatients in Ghana: a multi-centre point prevalence survey. BMC Pediatr. 2018;18(1):391.
   PubMedGoogle Scholar
• Zhang J-S, Liu G, Zhang W-S, et al. Antibiotic usage in Chinese children: a point prevalence survey. World J Pediatr. 2018;14(4):335–343.
   PubMed Web of Science ®Google Scholar
• Grohskopf LA, Huskins WC, Sinkowitz-Cochran RL, et al. Use of antimicrobial agents in United States neonatal and pediatric intensive care patients. Pediatr Infect Dis J. 2005;24(9):766–773.
   PubMed Web of Science ®Google Scholar
• Osowicki J, Gwee A, Noronha J, et al. Australia-wide point prevalence survey of the use and appropriateness of antimicrobial prescribing for children in hospital. Med J Aust. 2014;201(11):657–662.
   PubMed Web of Science ®Google Scholar
• Amadeo B, Zarb P, Muller A, et al. European Surveillance of Antibiotic Consumption (ESAC) point prevalence survey 2008: paediatric antimicrobial prescribing in 32 hospitals of 21 European countries. J Antimicrob Chemother. 2010;65(10):2247-2252.
   Web of Science ®Google Scholar
• Ufer M, Radosević N, Vogt A, et al. Antimicrobial drug use in hospitalised paediatric patients: a cross‐national comparison between Germany and Croatia. Pharmacoepidemiol Drug Saf. 2005;14(10):735–739.
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Versporten A, et al. A multicenter point prevalence survey of antibiotic use in Punjab, Pakistan: findings and implications. Expert Rev Anti Infect Ther. 17(4): 285–293. 2019.
   PubMed Web of Science ®Google Scholar
• Ren N, Zhou P, Wen X, et al. Point prevalence survey of antimicrobial use in Chinese hospitals in 2012. Am J Infect Control. 2016;44(3):332–339.
   PubMed Web of Science ®Google Scholar
• Zou -X-X, Fang Z, Min R, et al. Is nationwide special campaign on antibiotic stewardship program effective on ameliorating irrational antibiotic use in China? Study on the antibiotic use of specialized hospitals in China in 2011–2012. J Huazhong Univ Sci Technol Med Sci. 2014;34(3):456–463.
   PubMedGoogle Scholar
• Hou D, Wang Q, Jiang C, et al. Evaluation of the short-term effects of antimicrobial stewardship in the intensive care unit at a tertiary hospital in China. PloS One. 2014;9(7):e101447.
   PubMed Web of Science ®Google Scholar
• Oduyebo O, Olayinka A, Iregbu K, et al. A point prevalence survey of antimicrobial prescribing in four Nigerian Tertiary Hospitals. Ann Trop Pathol. 2017;8(1):42.
   Google Scholar
• Anand Paramadhas BD, Tiroyakgosi C, Mpinda-Joseph P, et al. Point prevalence study of antimicrobial use among hospitals across Botswana; findings and implications. Expert Rev Anti Infect Ther. 2019;17(7):535–546.
   PubMed Web of Science ®Google Scholar
• Wambale J, Mulwahali E, Iyamba J-ML, et al. Point prevalence study of antibiotic use in hospitals in Butembo. Int J Med Med Sci. 2016;8(12):133–139.
   Google Scholar
• Antonioli P, Manzalini MC, Stefanati A, et al. Temporal trends of healthcare associated infections and antimicrobial use in 2011–2013, observed with annual point prevalence surveys in Ferrara University Hospital, Italy. J Prev Med Hyg. 2016;57(3):E135.
   PubMedGoogle Scholar
• Cai Y, Venkatachalam I, Tee NW, et al. Prevalence of healthcare-associated infections and antimicrobial use among adult inpatients in Singapore acute-care hospitals: results from the first national point prevalence survey. Clin Infect Dis. 2017;64:S61–S67.
   PubMed Web of Science ®Google Scholar
• Okoth C, Opanga S, Okalebo F, et al. Point prevalence survey of antibiotic use and resistance at a referral hospital in Kenya: findings and implications. Hosp Pract. 2018;46(3):128-136.
   Google Scholar
• Magill SS, Edwards JR, Beldavs ZG, et al. Prevalence of antimicrobial use in US acute care hospitals, May-September 2011. Jama. 2014;312(14):1438–1446.
   PubMed Web of Science ®Google Scholar
• Zarb P, Amadeo B, Muller A, et al. Identification of targets for quality improvement in antimicrobial prescribing: the web-based ESAC point prevalence survey 2009. J Antimicrob Chemother. 2011;66(2):443–449.
   PubMed Web of Science ®Google Scholar
• Berild D, Ringertz SH, Lelek M. Appropriate antibiotic use according to diagnoses and bacteriological findings: report of 12 point-prevalence studies on antibiotic use in a university hospital. Scand J Infect Dis. 2002;34(1):56–60.
   PubMed Web of Science ®Google Scholar
• Cox JA, Vlieghe E, Mendelson M, et al. Antibiotic stewardship in low- and middle-income countries: the same but different? Clin Microbiol Infect. 2017;23(11):812–818.
   PubMed Web of Science ®Google Scholar
• Fadare JO, Ogunleye O, Iliyasu G, et al. Status of antimicrobial stewardship programmes in Nigerian tertiary healthcare facilities: findings and implications. J Glob Antimicrob Resist. 2018;17:132–136.
   PubMed Web of Science ®Google Scholar
• Kalungia AC, Mwambula H, Munkombwe D, et al. Antimicrobial stewardship knowledge and perception among physicians and pharmacists at leading tertiary teaching hospitals in Zambia: implications for future policy and practice. J Chemother. 2019;31(7–8):378–387.
   PubMed Web of Science ®Google Scholar
• Saleem Z, Hassali MA, Godman B, et al. A multicenter point prevalence survey of healthcare-associated infections in Pakistan: findings and implications. Am J Infect Control. 2019;47(4):421–424.
   PubMed Web of Science ®Google Scholar
• Mwita JC, Souda S, Magafu M, et al. Prophylactic antibiotics to prevent surgical site infections in Botswana: findings and implications. Hosp Pract. 2018;46(3):97–102.
   PubMedGoogle Scholar
• Mpinda-Joseph P, Anand Paramadhas BD, Reyes G, et al. Healthcare-associated infections including neonatal bloodstream infections in a leading tertiary hospital in Botswana. Hosp Pract. 2019;47(4):203–210.
   PubMedGoogle Scholar
• Labi AK, Obeng-Nkrumah N, Owusu E, et al. Multi-centre point-prevalence survey of hospital-acquired infections in Ghana. J Hosp Infect. 2019;101(1):60–68.
   PubMed Web of Science ®Google Scholar
• Yevutsey SK, Buabeng KO, Aikins M, et al. Situational analysis of antibiotic use and resistance in Ghana: policy and regulation. BMC Public Health. 2017;17(1):89.
   PubMedGoogle Scholar
• Mtapuri-Zinyowera S, Madzikwa N, Ndhlovu M. The first point-prevalence survey in different hospital settings in Zimbabwe. 2017;3:8. Available from:. http://muria.mandela.ac.za/muria/media/Store/documents/Abstract%20book%20-%20MURAI%203/MURIA3-AbstractBook-July-2017.pdf.
   Google Scholar
• Afriyie DK, Sefah IA, Sneddon J, et al. Antimicrobial point prevalence surveys in two Ghanaian hospitals: opportunities for antimicrobial stewardship. JAC Antimicrob Resist. 2020;2(1):1–9.
   Google Scholar
• Abubakar U. Antibiotic use among hospitalized patients in northern Nigeria: a multicenter point-prevalence survey. BMC Infect Dis. 2020;20(1):86.
   PubMed Web of Science ®Google Scholar
• Kiguba R, Karamagi C, Bird SM. Extensive antibiotic prescription rate among hospitalized patients in Uganda: but with frequent missed-dose days. J Antimicrob Chemother. 2016;71(6):1697.
   PubMed Web of Science ®Google Scholar
• Labi A-K, Obeng-Nkrumah N, Nartey ET, et al. Antibiotic use in a tertiary healthcare facility in Ghana: a point prevalence survey. Antimicrob Resist Infect Control. 2018;7(1):15.
   PubMedGoogle Scholar
• Gould I. Antibiotic resistance: the perfect storm. Int J Antimicrob Agents. 2009;34:S2–S5.
   PubMed Web of Science ®Google Scholar
• Jean -S-S, Hsueh P-R. High burden of antimicrobial resistance in Asia. Int J Antimicrob Agents. 2011;37(4):291–295.
   PubMed Web of Science ®Google Scholar
• Tadesse BT, Ashley EA, Ongarello S, et al. Antimicrobial resistance in Africa: a systematic review. BMC Infect Dis. 2017;17(1):616.
   PubMedGoogle Scholar
• Righi E, Peri AM, Harris PN, et al. Global prevalence of carbapenem resistance in neutropenic patients and association with mortality and carbapenem use: systematic review and meta-analysis. J Antimicrob Chemother. 2016;72(3):668–677.
   Web of Science ®Google Scholar
• Li DX, Cosgrove SE. Antimicrobial stewardship: efficacy and implementation of strategies to address antimicrobial overuse and resistance. Antimicrobial Stewardship. 2017;2:13.
   Google Scholar
• Hawkey P. Multidrug-resistant Gram-negative bacteria: a product of globalization. J Hosp Infect. 2015;89(4):241–247.
   PubMed Web of Science ®Google Scholar
• Jones RN, Guzman-Blanco M, Gales AC, et al. Susceptibility rates in Latin American nations: report from a regional resistance surveillance program (2011). Braz J Infect Dis. 2013;17(6):672–681.
   PubMed Web of Science ®Google Scholar
• Bartoloni A, Pallecchi L, Riccobono E, et al. Relentless increase of resistance to fluoroquinolones and expanded‐spectrum cephalosporins in Escherichia coli: 20 years of surveillance in resource‐limited settings from Latin America. Clin Microbiol Infect. 2013;19(4):356–361.
   PubMed Web of Science ®Google Scholar
• Shields RK, Nguyen MH, Chen L, et al. Ceftazidime-avibactam is superior to other treatment regimens against carbapenem-resistant klebsiella pneumoniae bacteremia. Antimicrob Agents Chemother. 2017;61(8):e00883–17.
   PubMed Web of Science ®Google Scholar
• Suay-García B, Pérez-Gracia MT. Present and future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections. Antibiotics. 2019;8:3.
   Google Scholar
• Effah CY, Sun T, Liu S, et al. Klebsiella pneumoniae: an increasing threat to public health. Ann Clin Microbiol Antimicrob. 2020;19(1):1.
   PubMed Web of Science ®Google Scholar
• Lusignani LS, Blacky A, Starzengruber P, et al. A national point prevalence study on healthcare-associated infections and antimicrobial use in Austria. Wien Klin Wochenschr. 2016;128(3–4):89–94.
   PubMed Web of Science ®Google Scholar
• Levy E, Swami S, Dubois S, et al. Rates and appropriateness of antimicrobial prescribing at an academic children’s hospital, 2007–2010. Infect Control Hosp Epidemiol. 2012;33(4):346–353.
   PubMed Web of Science ®Google Scholar
• Phu VD, Wertheim HF, Larsson M, et al. Burden of hospital acquired infections and antimicrobial use in Vietnamese adult intensive care units. PloS One. 2016;11(1):e0147544.
   PubMed Web of Science ®Google Scholar
• Versporten A, Sharland M, Bielicki J, et al. The antibiotic resistance and prescribing in European Children project: a neonatal and pediatric antimicrobial web-based point prevalence survey in 73 hospitals worldwide. Pediatr Infect Dis J. 2013;32(6):e242–53.
   PubMed Web of Science ®Google Scholar
• Robert J, Pean Y, Varon E, et al. Point prevalence survey of antibiotic use in French hospitals in 2009. J Antimicrob Chemother. 2012;67(4):1020–1026.
   Web of Science ®Google Scholar
• Nakwatumbah S, Kibuule D, Godman B, et al. Compliance to guidelines for the prescribing of antibiotics in acute infections at Namibia’s national referral hospital: a pilot study and the implications. Expert Rev Anti Infect Ther. 2017;15(7):713–721.
   PubMed Web of Science ®Google Scholar
• Niaz Q, Godman B, Massele A, et al. Validity of World Health Organisation prescribing indicators in Namibia’s primary healthcare: findings and implications. Int J Qual Health Care. 2019;31(5):338–345.
   PubMed Web of Science ®Google Scholar
• Hajdu A, Samodova O, Carlsson T, et al. A point prevalence survey of hospital-acquired infections and antimicrobial use in a paediatric hospital in north-western Russia. J Hosp Infect. 2007;66(4):378–384.
   PubMed Web of Science ®Google Scholar
• Sviestina I, Mozgis D. Antimicrobial usage among hospitalized children in Latvia: a neonatal and pediatric antimicrobial point prevalence survey. Medicina (B Aires). 2014;50(3):175–181.
   Google Scholar
• Usluer G, Ozgunes I, Leblebicioglu H. A multicenter point-prevalence study: antimicrobial prescription frequencies in hospitalized patients in Turkey. Ann Clin Microbiol Antimicrob. 2005;4(1):16.
   PubMedGoogle Scholar
• Lob SH, Hoban DJ, Sahm DF, et al. Regional differences and trends in antimicrobial susceptibility of Acinetobacter baumannii. Int J Antimicrob Agents. 2016;47(4):317–323.
   PubMed Web of Science ®Google Scholar
• Sturm A, Van der Pol R, Smits A, et al. Over-the-counter availability of antimicrobial agents, self-medication and patterns of resistance in Karachi, Pakistan. J Antimicrob Chemother. 1997;39(4):543–547.
   PubMed Web of Science ®Google Scholar
• Kalaba M, Kosutic J, Godman B, et al. Experience with developing antibiotic stewardship programs in Serbia: potential model for other Balkan countries? J Comp Eff Res. 2018;7(3):247–258.
   PubMed Web of Science ®Google Scholar
• Nusrat T, Akter N, Rahman NA, et al. Antibiotic resistance and sensitivity pattern of metallo-β-lactamase producing gram-negative bacilli in ventilator-associated pneumonia in the intensive care unit of a public medical school hospital in Bangladesh. Hosp Pract. 2020; EPrint. DOI:10.1080/21548331.2020.1754687
   Google Scholar
• Zellweger RM, Carrique-Mas J, Limmathurotsakul D, et al. A current perspective on antimicrobial resistance in Southeast Asia. J Antimicrob Chemother. 2017;72(11):2963–2972.
   PubMed Web of Science ®Google Scholar
• Okeke IN, Klugman KP, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part II: strategies for containment. Lancet Infect Dis. 2005;5(9):568–580.
   PubMed Web of Science ®Google Scholar
• Okeke IN, Laxminarayan R, Bhutta ZA, et al. Antimicrobial resistance in developing countries. Part I: recent trends and current status. Lancet Infect Dis. 2005;5(8):481–493.
   PubMed Web of Science ®Google Scholar
• Riaz H, Godman B, Hussain S, et al. Prescribing of bisphosphonates and antibiotics in Pakistan: challenges and opportunities for the future. J Pharm Health Serv Res. 2015;6(2):111–121.
   Google Scholar
• Ogunleye OO, Fadare JO, Yinka-Ogunleye AF, et al. Determinants of antibiotic prescribing among doctors in a Nigerian urban tertiary hospital. Hosp Pract (1995). 2019;47(1):53–58.
   PubMedGoogle Scholar
• Sharmin R, Sharmin ZR, Mosaddek AS, et al. Medicine promotional literature as a source of updated information in Bangladesh: do those advertising literature promote continued medical education or deceptive advertising? Acta Med Int. 2017;4(2):20–25.
   Google Scholar
• Van Dijck C, Vlieghe E, Cox JA. Antibiotic stewardship interventions in hospitals in low-and middle-income countries: a systematic review. Bull World Health Organ. 2018;96(4):266–280.
   PubMed Web of Science ®Google Scholar
• Honda H, Ohmagari N, Tokuda Y, et al. Antimicrobial stewardship in inpatient settings in the Asia Pacific region: a systematic review and meta-analysis. Clin Infect Dis. 2017;64(suppl_2):S119–s26.
   PubMedGoogle Scholar
• Nathwani D, Varghese D, Stephens J, et al. Value of hospital antimicrobial stewardship programs [ASPs]: a systematic review. Antimicrob Resist Infect Control. 2019;8:35.
   PubMed Web of Science ®Google Scholar
• Newton JA, Robinson S, Ling CLL, et al. Impact of procalcitonin levels combined with active intervention on antimicrobial stewardship in a Community Hospital. Open Forum Infect Dis. 2019;6:11.
   Web of Science ®Google Scholar
• Charani E, Smith I, Skodvin B, et al. Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study. PloS One. 2019;14(1):e0209847–e.
   PubMed Web of Science ®Google Scholar
• Kollef MH, Micek ST. Rational use of antibiotics in the ICU: balancing stewardship and clinical outcomes. Jama. 2014;312(14):1403–1404.
   PubMed Web of Science ®Google Scholar
• Kotwani A, Wattal C, Joshi P, et al. Irrational use of antibiotics and role of the pharmacist: an insight from a qualitative study in New Delhi, India. J Clin Pharm Ther. 2012;37(3):308–312.
   PubMed Web of Science ®Google Scholar
• Shehab N, Patel PR, Srinivasan A, et al. Emergency department visits for antibiotic-associated adverse events. Clin Infect Dis. 2008;47(6):735–743.
   PubMed Web of Science ®Google Scholar
• Prasad R, Gupta N, Singh M. Multidrug resistant tuberculosis: trends and control. Indian J Chest Dis Allied Sci. 2014;56(4):237–246.
   PubMedGoogle Scholar
• Fürst J, Čižman M, Mrak J, et al. The influence of a sustained multifaceted approach to improve antibiotic prescribing in Slovenia during the past decade: findings and implications. Expert Rev Anti Infect Ther. 2015;13(2):279–289.
   PubMed Web of Science ®Google Scholar
• Godman B, Haque M, McKimm J, et al. Ongoing strategies to improve the management of upper respiratory tract infections and reduce inappropriate antibiotic use particularly among lower and middle-income countries: findings and implications for the future. Curr Med Res Opin. 2020;36(2):301–327.
   PubMed Web of Science ®Google Scholar
• Abilova V, Kurdi A, Godman B. Ongoing initiatives in Azerbaijan to improve the use of antibiotics; findings and implications. Expert Rev Anti Infect Ther. 2018;16(1):77–84.
   PubMed Web of Science ®Google Scholar
• Alrasheedy AA, Alsalloum MA, Almuqbil FA, et al. The impact of law enforcement on dispensing antibiotics without prescription: a multi-methods study from Saudi Arabia. Expert Rev Anti Infect Ther. 2020;18(1):87–89.
   PubMed Web of Science ®Google Scholar
• Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol. 2006;62(5):373–379.
   PubMed Web of Science ®Google Scholar